Tibet Aim Pharm (SZSE:002826) Operating Cash Flow per Share : ¥1.01 (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Operating Cash Flow per Share?

Tibet Aim Pharm's operating cash flow per share for the three months ended in Sep. 2024 was ¥0.35. Tibet Aim Pharm's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tibet Aim Pharm was 278.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Tibet Aim Pharm's Operating Cash Flow per Share or its related term are showing as below:

SZSE:002826' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -6.8 Med: 10 Max: 194.6
Current: 4

During the past 10 years, Tibet Aim Pharm's highest 3-Year average Operating Cash Flow per Share Growth Rate was 194.60% per year. The lowest was -6.80% per year. And the median was 10.00% per year.

SZSE:002826's 3-Year OCF Growth Rate is ranked worse than
52.87% of 783 companies
in the Drug Manufacturers industry
Industry Median: 6.1 vs SZSE:002826: 4.00

Tibet Aim Pharm Operating Cash Flow per Share Historical Data

The historical data trend for Tibet Aim Pharm's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Operating Cash Flow per Share Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.07

0.32

0.55

0.57

0.36

Tibet Aim Pharm Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	0.41	0.29	-0.04	0.35

Competitive Comparison of Tibet Aim Pharm's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Aim Pharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tibet Aim Pharm's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Aim Pharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tibet Aim Pharm's Price-to-Operating-Cash-Flow falls into.

Tibet Aim Pharm Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Tibet Aim Pharm's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	68.453	/	191.893
	=	0.36

Tibet Aim Pharm's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	67.706	/	192.682
	=	0.35

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.01

Tibet Aim Pharm Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Executives

Peng Hui	Director
Pang Guo Qiang	Directors, executives
Li Qian Jin	Securities Affairs Representative
Liu Hang	Supervisors

Tibet Aim Pharm Headlines

No Headlines